Core Insights - Ventripoint Diagnostics has developed ultrasound technology that rivals MRI in quality, aiming to scale its operations for broader market impact [1][3]. Company Overview - Ventripoint Diagnostics Ltd. is publicly traded on TSXV under the ticker VPT and OTC Pink under VPTDF [3]. - The company focuses on innovative diagnostic solutions, particularly in the field of congenital heart defects [3]. Industry Context - The interview series "Inside the Boardroom" provides insights from industry leaders, highlighting their strategies and challenges in the biotechnology sector [3]. - CEO.CA serves as a platform for investors to engage with executives and discuss emerging opportunities in the biotechnology landscape [2][5].